PFA
ELV icon

Pettinga Financial Advisors’s Elevance Health ELV Stock Holding History

Pettinga Financial Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Sell
756
-35
-4% -$13K 0.05% 122
2026
Q1 		$232K Sell
791
-21
-3% -$6.9K 0.04% 136
2025
Q4 		$285K Buy
812
+37
+5% +$12.5K 0.05% 119
2025
Q3 		$251K Hold
775
– – 0.05% 120
2025
Q2 		$301K Buy
775
+1
+0.1% +$402 0.07% 108
2025
Q1 		$337K Hold
774
– – 0.08% 97
2024
Q4 		$285K Buy
774
+1
+0.1% +$418 0.06% 109
2024
Q3 		$402K Buy
773
+1
+0.1% +$534 0.1% 87
2024
Q2 		$418K Hold
772
– – 0.1% 83
2024
Q1 		$400K Buy
772
+1
+0.1% +$497 0.1% 86
2023
Q4 		$364K Sell
771
-195
-20% -$90.2K 0.1% 91
2023
Q3 		$421K Sell
966
-315
-25% -$143K 0.13% 69
2023
Q2 		$569K Hold
1,281
– – 0.17% 54
2023
Q1 		$589K Buy
1,281
+1
+0.1% +$476 0.18% 52
2022
Q4 		$657K Hold
1,280
– – 0.21% 59
2022
Q3 		$581K Buy
1,280
+312
+32% +$149K 0.2% 59
2022
Q2 		$467K Buy
968
+7
+0.7% +$3.46K 0.14% 68
2022
Q1 		$472K Buy
961
+6
+0.6% +$2.74K 0.12% 75
2021
Q4 		$443K Buy
955
+7
+0.7% +$2.94K 0.11% 78
2021
Q3 		$353K Buy
948
+8
+0.9% +$3.04K 0.09% 78
2021
Q2 		$359K Buy
940
+8
+0.9% +$3.06K 0.1% 77
2021
Q1 		$334K Buy
932
+8
+0.9% +$2.57K 0.1% 73
2020
Q4 		$297K Buy
924
+9
+1% +$2.76K 0.11% 70
2020
Q3 		$246K Buy
915
+8
+0.9% +$2.15K 0.1% 69
2020
Q2 		$239K Buy
+907
New +$242K 0.12% 67
2020
Q1 		– Sell
-800
Closed -$241K – 77
2019
Q4 		$241K Buy
+800
New +$220K 0.13% 76
2019
Q3 		– Sell
-789
Closed -$223K – 90
2019
Q2 		$223K Buy
789
+6
+0.8% +$1.64K 0.12% 85
2019
Q1 		$225K Buy
+783
New +$226K 0.12% 82

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pettinga Financial Advisors's ELV Position: Q2 2026 in Review

Pettinga Financial Advisors reduced its Elevance Health (ELV) stake by 4.4% in Q2 2026, selling an estimated $13K and leaving 756 shares worth $292K. The position accounts for 0.05% of the portfolio, ranked #122.

Pettinga Financial Advisors first reported a position in ELV in Q1 2019 and has held it in 28 quarters since. The position peaked at $657K in Q4 2022. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Pettinga Financial Advisors held 756 shares of Elevance Health worth $292K as of Q2 2026.
  • Pettinga Financial Advisors sold 35 Elevance Health shares in Q2 2026, an estimated $13K.
  • Elevance Health made up 0.05% of Pettinga Financial Advisors's portfolio in Q2 2026, its #122 holding.
  • Pettinga Financial Advisors first reported a position in Elevance Health in Q1 2019 and has held it in 28 quarters since.
  • Pettinga Financial Advisors's Elevance Health position peaked at $657K in Q4 2022.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pettinga Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.